The Right to Oncological Oblivion: A Legislative Response to Cancer Survivor Discrimination in Italy

Author:

D’Antonio Gianpiero1ORCID,Bolino Ginevra1,Sorace Letizia1,Volonnino Gianpietro1ORCID,Pellegrini Lavinia1,Di Fazio Nicola1,Frati Paola1ORCID

Affiliation:

1. Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00128 Rome, Italy

Abstract

Despite the increasing efficacy of modern medicine in diagnosing and treating cancer, survivors often face discrimination in employment, economics, insurance, and society. Law no. 193/2023, also known as the “Oncological Oblivion Law”, aims to provide an initial legislative response to discrimination against cancer survivors in Italy. After defining oncological oblivion in Article 1, the Law provides, in Articles 2, 3, and 4, directives to prevent discrimination against cancer survivors in the area of access to banking and insurance services, adoption procedures and access to or retention in employment. The aim of this work is to illustrate the content and the critical aspects of the recent Law 193/2023 in the landscape of European directives. The legislative process at the Chamber of Deputies and the Senate of the Italian Republic has been retraced through the consultation of preparatory works and bills registered on institutional databases. Law 193/2023 represents the first initiative in Italy aimed at the recognition of the right to oncological oblivion, not only in access to banking and insurance services as in other countries, but also in adoption, employment, and re-employment. Our opinion piece highlights the need for further clarification and expansion to prevent discrimination and protect the social–work–relational rights of people who have been affected by oncological diseases.

Publisher

MDPI AG

Reference38 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018;Ferlay;Eur. J. Cancer,2018

2. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers;Dyba;Eur. J. Cancer,2021

3. WHO (2024, January 16). International Agency for Research on Cancer. Cancer Tomorrow Program, Available online: https://gco.iarc.fr/tomorrow/en/.

4. (2024, January 10). Communication from the European Commission to the European Parliament and the Council Empty—European Plan to Combat Cancer. Brussels, 3 February 2021. Available online: https://eur-lex.europa.eu/legal-content/IT/TXT/HTML/?uri=CELEX:52021DC0044&from=hr.

5. Aiom (2024, January 16). The Numbers of Cancer in Italy. Available online: https://www.aiom.it/i-numeri-del-cancro-in-italia/.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3